-
Biotech companies finding new ways to do business globally
LONDON, U.K. | Biotech companies are exploring alternative options to supplement their in-house research and development, says healthcare intelligence provider GlobalData in a new report. These companies are abandoning the traditional blockbuster drug model to instead pursue deals and buy their way to success, GlobalData suggests.